1990
DOI: 10.1016/0304-3940(90)90555-n
|View full text |Cite
|
Sign up to set email alerts
|

Selective activation of phosphoinositide hydrolysis by a rigid analogue of glutamate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
40
0

Year Published

1991
1991
2012
2012

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 93 publications
(40 citation statements)
references
References 14 publications
0
40
0
Order By: Relevance
“…A weak but significant increase in inositol phosphate formation by AP3 has also been reported (Schoepp et al 1989). Moreover, AP4 has the following non-specific actions: first, the majority of [3H]AP4 binding represents a Glu uptake site, not a receptor (Kessler, Baudry & Lynch, 1987); second, L-AP4 behaves as a non-specific Glu antagonist and as a non-specific inhibitor of IP3 formation (Evans, Francis, Jones, Smith & Watkins, 1982;Desai & Conn, 1990;Izumi et al 1991); and third, AP4 itself is an agonist of the Glu receptor (Evans et al 1982;Schoepp & Johnson, 1989;Adamson et al 1990;Trombley & Westbrook, 1992). In the present preparation, AP4 at high concentrations induced inward currents as well.…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…A weak but significant increase in inositol phosphate formation by AP3 has also been reported (Schoepp et al 1989). Moreover, AP4 has the following non-specific actions: first, the majority of [3H]AP4 binding represents a Glu uptake site, not a receptor (Kessler, Baudry & Lynch, 1987); second, L-AP4 behaves as a non-specific Glu antagonist and as a non-specific inhibitor of IP3 formation (Evans, Francis, Jones, Smith & Watkins, 1982;Desai & Conn, 1990;Izumi et al 1991); and third, AP4 itself is an agonist of the Glu receptor (Evans et al 1982;Schoepp & Johnson, 1989;Adamson et al 1990;Trombley & Westbrook, 1992). In the present preparation, AP4 at high concentrations induced inward currents as well.…”
Section: Discussionmentioning
confidence: 94%
“…Recently, pharmacological and molecular biological studies suggested the presence of more than ten subtypes of mGluR in the mammalian brain (Sladeczek et al 1988;Henley & Johnston, 1991;Houamed et al 1991;Tanabe, Ito & Sugiyama, 1991;Vecil, Li & Warsh, 1991;Nakanishi, 1992). Regionally different localization of mGluRs in the brain has also been reported (Desai & Conn, 1990;Nakanishi, 1992). Therefore, it is of great interest to discover what functional roles these mGluR subtypes might play in the mammalian CNS.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The responses in the present study were well maintained throughout the recording period (up to 1 h). Furthermore, we have been unable, so far, to detect resolvable single-channel currents under the patch pipette in cell-attached patches (not exposed to agonist) when the rest of the cell is exposed to either glutamate, quisqualate or trans-ACPD (trans-D,L-1-amino-1,3-cyclopentane-dicarboxylic acid), a selective agonist for the quisqualate 'metabotropic' receptor (Desai & Conn, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…Studies on the role of metabotropic receptors have proliferated since the compound trans-1 -aminocyclopentane-1,3-dicarboxylic acid (tACPD) was shown to be a selective agonist (Palmer, Monaghan & Cotman, 1989;Manzoni et al 1990;Desai & Conn, 1990). Activation of mGluR by tACPD or by quisqualate reduces potassium currents of hippocampal neurones (Charpak, Gahwiler, Do & Knopfel, 1990;Baskys, Bernstein, Barolet & Carlen, 1990).…”
mentioning
confidence: 99%